This worked out well.
No clarity on peer review, patents, TGA Provisional Approval, lack of public KOL endorsement, lack of institutional investment, if they will guzump all the timelines to push for a DMOAD label before NDA whilst there is absolutely no clear pathway.
I could say I told you so, so I will.
- Forums
- ASX - By Stock
- PAR
- PAR Investor Meeting - Questions from HC
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
0.00%
!
41.0¢

PAR Investor Meeting - Questions from HC, page-58
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
41.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $162.9M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2500 | 41.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.5¢ | 12500 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2500 | 0.410 |
6 | 23388 | 0.400 |
5 | 92140 | 0.395 |
4 | 46650 | 0.390 |
4 | 79000 | 0.385 |
Price($) | Vol. | No. |
---|---|---|
0.385 | 12500 | 2 |
0.400 | 35500 | 1 |
0.420 | 51400 | 2 |
0.425 | 9000 | 2 |
0.430 | 28500 | 1 |
Last trade - 09.48am 18/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
Day chart unavailable